Perspective · 10 Sep 2026
Conference abstractPublished 20 Jul 2015
Pre-clinical evaluation of an Interleukin- 6 antagonist in inflammatory arthritis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The cellular and molecular signals that safeguard the architecture of the joint during an acute flare of inflammatory arthritis are ill defined. Published data from our group clearly identifies interleukin-6 (IL-6) signaling pathway as important factors that alter early inflammation, tissue homeostasis and tissue damage (1-3). We use relevant cell-based in vitro assays and in vivo models to assign specific IL-6 mediated molecular mechanisms that regulate degenerative cell functionality. We also explore the potential value of a pertinent IL-6-directed antagonist as a preventative therapy for early joint injury during experimental inflammatory arthritis. The manner by which the IL-6 pathway regulates cell trafficking during arthritis is characterized and its impact upon bone homeostasis is assessed.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Anwen S Williams”
